Public-registry site landscape for NCT05232825, a Relapsing Multiple Sclerosis study sponsored by Hoffmann-La Roche. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05232825 (registry record) |
| Sponsor | Hoffmann-La Roche |
| Condition(s) | Relapsing Multiple Sclerosis; Primary Progressive Multiple Sclerosis |
| Phase | PHASE3 |
| Listed sites | 37 |
| Site countries | United States, Brazil, Czechia, Italy, New Zealand, Poland, Spain, Turkey (Türkiye) |
Eichor generates a preliminary site-risk snapshot for NCT05232825 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →